Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Nerve Tissue, central nervous system cancer, meningioma, neoplasm, nervous system disorder, tumor of meninges, vascular cancer	Recruiting	Phase 1 / Phase 2	2025-04-13		NCT04997317

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Swiss Cancer League	4
University Hospital, Basel, Switzerland	243

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital Basel, Department of Neurosurgery	Basel	Switzerland	1

Clinical trials